Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4772037

O=C(Nc1ccc2c(c1)CCN(C1CCC1)CC2)c1onc2ccccc12.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
HRH3 Q9Y5N1 7/20 0.40
ROCK1 Q13464 1/20 0.40
NPC1 O15118 2/20 0.40
TP53 P04637 2/20 0.40
NFKB1 P19838 2/20 0.40
HTT P42858 2/20 0.40
RAB9A P51151 2/20 0.40
NFKB2 Q00653 2/20 0.40
RELA Q04206 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 1/20 0.40
RBP4 P02753 1/20 0.39
MGAT2 Q10469 1/20 0.38
CYP2D6 P10635 2/20 0.38
USP2 O75604 1/20 0.38
MAPT P10636 2/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772503 0.95 MEN1 (0.45) KMT2AMEN1HRH3ROCK1NPC1
Trifluoroacetic Acid SCHEMBL4765701 0.81 MAPT (0.48) SLC2A1KMT2AMEN1HRH3NPC1
Trifluoroacetic Acid SCHEMBL4772033 0.81 MEN1 (0.44) SLC2A1KMT2AMEN1HRH3NPC1
Trifluoroacetic Acid SCHEMBL4774158 0.81 TMPRSS2 (0.55) SLC2A1KMT2AMEN1NPC1TP53
Trifluoroacetic Acid SCHEMBL4775088 0.81 MAP4K1 (0.52)
Trifluoroacetic Acid SCHEMBL4765215 0.81 SMN1; SMN2 (0.47) SLC2A1HRH3NPC1TP53NFKB1
Trifluoroacetic Acid SCHEMBL4774309 0.80 ABCB1 (0.50) SLC2A1KMT2AMEN1HRH3NPC1
Trifluoroacetic Acid SCHEMBL4769820 0.80 ALDH1A1 (0.46) SLC2A1KMT2AMEN1HRH3NPC1
Trifluoroacetic Acid SCHEMBL4765765 0.79 TP53 (0.50) SLC2A1KMT2AMEN1HRH3NPC1
Trifluoroacetic Acid SCHEMBL4768284 0.79 HRH3 (0.46) SLC2A1KMT2AMEN1HRH3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 SLC2A1 4665/4885KMT2A 99/4885MEN1 2213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.